Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol

Authors:

Abstract
BACKGROUND It has been shown that the route of administration of misoprostol has a strong impact on the pharmacokinetic profile and result in different clinical efficacy. No study has so far evaluated the pharmacokinetics beyond 6 hours. Furthermore a new slow-release misoprostol formulation was included in the study.